Popular Articles
Burdock Root

New Form Of Targeted Antibody Therapy Offers Further Hope To Patients With Incurable HER2-positive Breast Cancer
Final results from a phase II study presented at ASCO show that 25% of women with advanced HER2-positive breast cancer experienced significant shrinkage of their tumours, when treated with a first in class combination antibody called trastuzumab-DM1 (T-DM1). T-DM1 potentially represents another option for patients with metastatic disease, for which there is no cure.
generic viagra online
Breakthrough Breast Cancer Scientists Develop New Method To Predict Patient Response To Herceptin
Breakthrough Breast Cancer scientists have taken a significant step towards personalising cancer treatment by developing a method to predict a patient"s response to the drug Herceptin.
News of the day
ACOG Endorses Full Equity For CNM(R) And CM(R) Reimbursement Under Medicare
The American College of Nurse-Midwives (ACNM), the nation"s oldest women"s health organization, is pleased to announce that the American College of Obstetricians and Gynecologists (ACOG) has reaffirmed its support for equitable reimbursement for certified nurse-midwives (CNMs) and certified midwives (CMs) within the Medicare program, a priority legislative initiative for ACNM members.
Public Health

Informa Healthcare Journals To Unite On One Platform - Pharmaceutical Science And Medicine Journals Create Robust Information Service For Customers

Informa Healthcare - one of the world"s leading medical and scientific publishers- has announced that its peer-reviewed medical titles will be joining the company"s pharmaceutical science titles to form one, united platform for drug discovery and clinical medicine on http://www.Informahealthcare.com. The combination of medicine and pharmaceutical science titles simplifies the customer experience in one new, easy to use, robust platform that will deliver online content and archive material from more than 170 journals. All of the journals will utilize the online content management and delivery system provided by Atypon Systems, Inc. - a platform provider for over 70 information providers including JSTOR, New England Journal of Medicine and the American Chemical Society. The new platform offers the option of online trials, advanced searching, alerting, and single article purchases. In addition, the Atypon system enables Informa Healthcare to integrate the online content of over 170 journals with a comprehensive archive service, giving pharmaceutical and healthcare professionals one central, high-quality of information spanning the fields of medicine and pharmaceutical science. The beta site on the new platform is scheduled for release in summer 2009 and the complete transition will continue through to the end of this calendar year. "Our flexible technical architecture allows us to deploy functionally rich web sites tailored to the needs of particular information sectors. We are delighted to have delivered a cost-effective solution that addresses the specific needs of clinical medicine, pharmaceutical and allied markets for Informa Healthcare," says Chris Beckett, Vice President of Sales and Marketing - Atypon Systems. "We are excited to be able to offer this one-stop-shop hosting platform for our customers," said Phil Garner, Publishing Director at Informa Healthcare. "This new platform means that healthcare, academic and corporate professionals will have one central, high-quality of information spanning the drug discovery and clinical medicine fields from bench to bedside - including a comprehensive and easy-to-use archive service dating back to 1921." Informa Healthcare is encouraging customer feedback throughout the transition process. Subscribers will have a chance to send feedback and post questions about the beta site, and Informa is doing everything possible to make the transition as seamless and easy as possible. There will be a dual-hosting period with the informaworld platform, which currently hosts the content, through 2009 allowing for a gradual migration and the site will provide reports and statistics to help subscribers analyze usage. "This new improved service provides users with outstanding navigation and functionality and is all about bringing together quality information and addressing the needs of our readers with the touch of a button," explained Phil. "Until now, users had to duplicate their searches across the different platforms or miss out on coverage in their interest area because it was published elsewhere. Now, readers will be pointed from one article towards other articles of interest within the http://www.Informahealthcare.com site. Informa Healthcare


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):